If you have COPD, there are some things that can cause the disease to flare up. This is referred to as “COPD exacerbation.” Some of the most common causes of COPD exacerbation include: When you have ...

If you have COPD, the sounds made by your lungs can help your doctor evaluate the state of your airways and whether your treatment is working. Types of COPD lung sounds include wheezing, crackling, ...

Please provide your email address to receive an email when new articles are posted on . Patients with COPD experienced several improvements with 3 mg of twice-daily ensifentrine over 24 weeks.

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Witt: I'm so glad ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. At the moment, targeted lung denervation as a treatment ...

Researchers found that cough reflex sensitivity is amplified during chronic obstructive pulmonary disease (COPD) exacerbation and reduces after recovery, while its persistence can help serve as a ...

The CT-based whole-lung radiomic nomogram accurately identifies AECOPD and offers a robust tool for clinical diagnosis and treatment planning.

Chronic obstructive pulmonary disease (COPD) is a long-term lung disease affecting at least 15 million American adults. It’s also the fourth leading cause of disease-attributed death. This makes ...

Exacerbations of chronic obstructive pulmonary disease (COPD) accelerate the loss of lung function especially among patients with mild disease, according to researchers at National Jewish Health and ...

Credit: Getty Images. Ensifentrine (RPL554) is a first-in-class, dual phosphodiesterase (PDE) 3 and 4 inhibitor with combined bronchodilator and anti-inflammatory actions. Treatment with nebulized ...

Dupilumab is the first biologic to significantly improve lung function in chronic obstructive pulmonary disease (COPD), according to topline results released Thursday. A pivotal phase 3 trial of ...

Previous studies have shown a benefit of beta-blockers in the reduction of exacerbations and death in patients with COPD, despite the presence of cardiac disease. A recent study hypothesized that the ...